BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
During the Trading Day
| 1.79 |  +0.09 / +5.29% |
Data as of 4:00pm ET | Day’s Change |
During After-Hours Switch to standard view »
| 1.79 |  0.00 / 0.00% |
Volume: 14.1K |
Latest BCRX News | Press Releases
No recent news for BioCryst Pharmaceuticals Inc.
Today’s Trading
| Previous close | 1.70 |
| Today’s open | 1.70 |
| Day’s range | 1.70 - 1.83 |
| Volume | 1,243,196 |
| Average volume (3 months) | 1,588,115 |
| Market cap | $90.3M |
| Dividend yield | -- |
Data as of 4:00pm ET, 06/18/2013
Growth & Valuation
| Earnings growth (last year) | +37.30% |
| Earnings growth (this year) | +42.41% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +33.85% |
| P/E ratio | NM |
| Price/Sales | 2.67 |
| Price/Book | -- |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| PSDVpSivida Corp | +0.12 | +3.23% |
| AGENAgenus Inc | +0.03 | +0.80% |
| CURNeuralstem Inc | -0.03 | -2.11% |
| PIPPharmAthene Inc | +0.01 | +0.64% |
Data as of 4:01pm ET, 06/18/2013
Financials
| Next reporting date | August 6, 2013 |
| EPS forecast (this quarter) | -$0.14 |
| Annual revenue (last year) | $26.3M |
| Annual profit (last year) | -$39.1M |
| Net profit margin | -148.64% |
Profile
Sector Health Technology |
Industry Biotechnology |
President, Chief Executive Officer & Director Jon P. Stonehouse |
Chief Financial Officer, Treasurer, CAO & SVP Thomas R. Staab, II, CPA |
Corporate headquarters Birmingham, Alabama |
Forecasts
